U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Commercial Serodiagnostic Tests for Diagnosis of Tuberculosis: Policy Statement. Geneva: World Health Organization; 2011.

Cover of Commercial Serodiagnostic Tests for Diagnosis of Tuberculosis

Commercial Serodiagnostic Tests for Diagnosis of Tuberculosis: Policy Statement.

Show details

4GRADE evidence profiles and final policy recommendations

The GRADE evidence assessment (Tables 1 to 4) confirmed that the quality of evidence for commercial serodiagnostic tests was very low, with harms/risks far outweighing any potential benefits (strong recommendation). It is therefore recommended that these tests should not be used in individuals suspected of active pulmonary or extra-pulmonary TB, irrespective of their HIV status.

  • This recommendation also applies to paediatric TB based on the generalisation of data from adults (while acknowledging the limitations of microbiological diagnosis in children);
  • This recommendation also applies to the use of commercial serodiagnostic tests as add-on tests in smear-negative individuals given the high risk of false-positives and the consequent adverse effects.
Copyright © World Health Organization 2011.

All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob).

Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press through the WHO web site (http://www.who.int/about/licensing/copyright_form/en/index.html).

Bookshelf ID: NBK304211

Views

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...